[1]
A. Piasecki, “Non-vitamin K antagonist oral anticoagulants (NOAC) in nonvalvular atrial fibrillation – in-group comparison”, Prosp. Pharm. Sc., vol. 20, no. 1, pp. 26–31, Jul. 2022.